First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

529 Reviews

Credit Rating - THE PHARM LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: THE PHARM LIMITED, 148 Fleet Road, London, NW3 2QX. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2023. The company was incorporated on 9 March 2006.

The accounts next due date is 31 December 2024. There are 2 mortgages, 2 satisfied, none part satisfied and none unsatisfied.

The above was based on public record information as at 24 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05737630
Date Incorporated: 9 March 2006
Date Latest Accounts: 31 March 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 05737630
Annual Return: 9 March 2016
Registered Office: 148 Fleet Road, London, NW3 2QX
SIC Code and Operations: 96020
SECURED CREDITORS
Number of Mortgages 2
Satisfied Mortgages 2
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

THE PHARM LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 6 March 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
08434293 THE PHARM RESEARCH LIMITED Active - Proposal to Strike off
10470918 THE PHARMA DEVELOPMENT AND MANUFACTURING CONSULTANCY LIMITED Active - Proposal to Strike off
14493663 THE PHARMA LEEDS LTD Active
07234765 THE PHARMA LETTER LIMITED Active
13306759 THE PHARMA LOOP LIMITED Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd